BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

927 related articles for article (PubMed ID: 15178255)

  • 1. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
    Lerch M; Mayrhofer M; Zerbe O
    J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
    Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
    Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
    Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
    Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine pancreatic polypeptide (bPP) undergoes significant changes in conformation and dynamics upon binding to DPC micelles.
    Lerch M; Gafner V; Bader R; Christen B; Folkers G; Zerbe O
    J Mol Biol; 2002 Oct; 322(5):1117-33. PubMed ID: 12367532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key motif to gain selectivity at the neuropeptide Y5-receptor: structure and dynamics of micelle-bound [Ala31, Pro32]-NPY.
    Bader R; Rytz G; Lerch M; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2002 Jun; 41(25):8031-42. PubMed ID: 12069594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
    Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
    Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards understanding the free and receptor bound conformation of neuropeptide Y by fluorescence resonance energy transfer studies.
    Haack M; Beck-Sickinger AG
    Chem Biol Drug Des; 2009 Jun; 73(6):573-83. PubMed ID: 19635049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PP-fold solution structure of human polypeptide YY and human PYY3-36 as determined by NMR.
    Nygaard R; Nielbo S; Schwartz TW; Poulsen FM
    Biochemistry; 2006 Jul; 45(27):8350-7. PubMed ID: 16819834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR studies of the low-density lipoprotein receptor-binding peptide of apolipoprotein E bound to dodecylphosphocholine micelles.
    Clayton D; Brereton IM; Kroon PA; Smith R
    Protein Sci; 1999 Sep; 8(9):1797-805. PubMed ID: 10493581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide architecture: adding an alpha-helix to the PYY lysine side chain provides nanomolar binding and body-weight-lowering effects.
    Pedersen SL; Sasikumar PG; Vrang N; Jensen KJ
    ChemMedChem; 2010 Apr; 5(4):545-51. PubMed ID: 20183851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
    Lindner D; van Dieck J; Merten N; Mörl K; Günther R; Hofmann HJ; Beck-Sickinger AG
    Biochemistry; 2008 Jun; 47(22):5905-14. PubMed ID: 18457425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C; Beck-Sickinger AG
    J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment.
    Doughty MB; Hu L
    Biopolymers; 1993 Aug; 33(8):1195-206. PubMed ID: 8364154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y/peptide YY receptor Y2 duplicate in zebrafish with unique introns displays distinct peptide binding properties.
    Fällmar H; Sundström G; Lundell I; Mohell N; Larhammar D
    Comp Biochem Physiol B Biochem Mol Biol; 2011 Dec; 160(4):166-73. PubMed ID: 21855645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical methods to study ligand-receptor interactions of neuropeptide Y.
    Bettio A; Beck-Sickinger AG
    Biopolymers; 2001; 60(6):420-37. PubMed ID: 12209475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
    Goumain M; Voisin T; Lorinet AM; Laburthe M
    Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular recognition of the NPY hormone family by their receptors.
    Lindner D; Stichel J; Beck-Sickinger AG
    Nutrition; 2008 Sep; 24(9):907-17. PubMed ID: 18725086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.